A Cross-over Trial to Identify Patient Characteristics That Predict Blood Pressure Response to Antihypertensive Therapy in General Practice.
Phase of Trial: Phase IV
Latest Information Update: 29 Apr 2012
At a glance
- Drugs Hydrochlorothiazide (Primary) ; Valsartan (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- Acronyms NAMIS
- 29 Apr 2012 Results presented at the 22nd European Meeting on Hypertension.
- 13 Feb 2012 Actual patient number 120 added as reported by ClinicalTrials.gov.
- 13 Feb 2012 Actual end date Mar 2011 added as reported by ClinicalTrials.gov.